Vaxcyte · 1 day ago
Document Control Specialist III
Vaxcyte is a clinical-stage vaccine innovation company focused on creating high-fidelity vaccines to combat bacterial diseases. They are seeking a Document Control Specialist who will manage GxP documentation within the Quality Management System, ensuring compliance and effective document workflows.
BiopharmaBiotechnologyHealth Care
Responsibilities
Maintain Quality System documentation in Veeva (electronic document control system) and other electronic systems where required
Format documents to comply with Vaxcyte templates
Independently perform the QA document control function, managing document workflows in Veeva, tracking, processing, routing, distributing, and archiving documents/records with overall responsibility for document control
Engage key clients to understand expectations and problem areas and has the ability to address and resolve conflicts
Participate in developing and editing of new SOPs and work instructions
Ability to identify risks to program/process and propose solutions
Work closely with functional areas for daily management of routing, revisions, approval, and filing of documents within defined timelines
Organize and ensure accurate and reliable filing systems for all electronic
Qualification
Required
Bachelor's BA/BS degree or equivalent experience and minimum of 5 years of biopharmaceutical industry experience. Other combinations of education and/or experience may be considered
Experience working with documents and records in a GxP environment relating to manufacturing and testing activities
Familiar with Veeva Vault in a Document Control capacity
Understanding of current regulatory expectations including 21CFR Part 11 requirements
Strong professional interpersonal and communications skills, both verbal and written, to provide clear direction for the business, vendors, and internal stakeholders
Strong attention to detail, organizational skills, ability to work in a faced paced environment
Ability to meet deadlines and multi-task efficiently
Proficient with Microsoft Office Suite, Word, Excel, PowerPoint
Benefits
Comprehensive benefits
An equity component
Company
Vaxcyte
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Funding
Current Stage
Public CompanyTotal Funding
$3.85BKey Investors
CARB-XTPG GrowthAbingworth
2024-09-04Post Ipo Equity· $1.5B
2024-01-30Post Ipo Equity· $862.5M
2023-04-19Post Ipo Equity· $500M
Leadership Team
Recent News
2025-12-09
Company data provided by crunchbase